Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KRT2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | STAR | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LRRC8B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BCL10 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SYT4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SLC35E2B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SALL2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | STAP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | FOXP2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PLD6 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |